A Ductal-Cell-Related Risk Model Integrating Single-Cell and Bulk Sequencing Data Predicts the Prognosis of Patients With Pancreatic Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a highly heterogeneous malignancy. Single-cell sequencing (scRNA-seq) technology enables quantitative gene expression measurements that underlie the phenotypic diversity of cells within a tumor. By integrating PDAC scRNA-seq and bulk sequencing data, we aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xitao, Dou, Xiaolin, Ren, Xinxin, Rong, Zhuoxian, Sun, Lunquan, Deng, Yuezhen, Chen, Pan, Li, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762279/
https://www.ncbi.nlm.nih.gov/pubmed/35047000
http://dx.doi.org/10.3389/fgene.2021.763636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762279/
https://www.ncbi.nlm.nih.gov/pubmed/35047000
http://dx.doi.org/10.3389/fgene.2021.763636

Ejemplares similares